Breaking News, Collaborations & Alliances

Cellular Origins, J&J Partner for CGT Robotics Manufacturing Platform

Aim to develop a scalable, end-to-end automated platform for autologous CAR-T cell manufacturing using Cellular Origins’ automated robotics platform.

Author Image

By: Charlie Sternberg

Associate Editor

Cellular Origins has entered into a collaboration with Johnson & Johnson to develop a scalable, end-to-end automated platform for autologous CAR-T cell manufacturing. Cellular Origins has successfully shown that its platform is able to fully automate cell therapy manufacturing processes using validated, off-the-shelf third-party instruments in combination with mobile robots and Cellular Origins’ proprietary sterile fluid transfer technology. As a next step, Cellular Origins is developing ...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters